These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19468997)

  • 21. The role of infection in the pathogenesis of spondyloarthropathies with special reference to human leukocyte antigen-B27.
    Penttinen MA; Liu Y; Granfors K
    Curr Rheumatol Rep; 2002 Dec; 4(6):518-24. PubMed ID: 12427368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Animal models of HLA-B27-associated diseases.
    Breban M; Hacquard-Bouder C; Falgarone G
    Curr Mol Med; 2004 Feb; 4(1):31-40. PubMed ID: 15011957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of gut inflammation in the pathogenesis of spondyloarthropathies.
    Mielants H; De Vos M; Cuvelier C; Veys EM
    Acta Clin Belg; 1996; 51(5):340-9. PubMed ID: 8950841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics in arthralgia and spondyloarthropathies in patients with inflammatory bowel disease. Prospective randomized trials are necessary.
    Karimi O; Peña AS
    Rev Esp Enferm Dig; 2005 Aug; 97(8):570-4. PubMed ID: 16266224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation.
    Meenan J; Spaans J; Grool TA; Pals ST; Tytgat GN; van Deventer SJ
    Gut; 1997 Feb; 40(2):241-6. PubMed ID: 9071939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intestines and joints: an entity?].
    De Vos M
    Verh K Acad Geneeskd Belg; 2002; 64(2):85-99; discussion 99-104. PubMed ID: 12085568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of bone strength in HLA-B27 transgenic rats is characterized by a high bone turnover and is mainly osteoclast-driven.
    Rauner M; Thiele S; Fert I; Araujo LM; Layh-Schmitt G; Colbert RA; Hofbauer C; Bernhardt R; Bürki A; Schwiedrzik J; Zysset PK; Pietschmann P; Taurog JD; Breban M; Hofbauer LC
    Bone; 2015 Jun; 75():183-91. PubMed ID: 25746795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.
    Ridley A; Hatano H; Wong-Baeza I; Shaw J; Matthews KK; Al-Mossawi H; Ladell K; Price DA; Bowness P; Kollnberger S
    Arthritis Rheumatol; 2016 Apr; 68(4):901-14. PubMed ID: 26841353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trafficking of antigens from gut to sacroiliac joints and spine in reactive arthritis and spondyloarthropathies: Mainly through lymphatics?
    Berthelot JM; Claudepierre P
    Joint Bone Spine; 2016 Oct; 83(5):485-90. PubMed ID: 26968111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy of spondylarthropathy in inflammatory bowel disease.
    Generini S; Fiori G; Matucci Cerinic M
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S88-94. PubMed ID: 12463455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors.
    Subramaniam K; Tymms K; Shadbolt B; Pavli P
    Intern Med J; 2015 Nov; 45(11):1154-60. PubMed ID: 26337851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined therapeutic approach: inflammatory bowel diseases and peripheral or axial arthritis.
    Atzeni F; Ardizzone S; Bertani L; Antivalle M; Batticciotto A; Sarzi-Puttini P
    World J Gastroenterol; 2009 May; 15(20):2469-71. PubMed ID: 19468996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of human leucocyte antigen class I free heavy chains on monocytes of patients with spondyloarthritis and cells transfected with HLA-B27.
    Ding J; Feng Y; Zheng ZH; Li XY; Wu ZB; Zhu P
    Int J Immunogenet; 2015 Feb; 42(1):4-10. PubMed ID: 25545293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteria-specific cytotoxic CD8+ T cells: a missing link in the pathogenesis of the HLA-B27-associated spondylarthropathies.
    Hermann E; Fleischer B; Meyer zum Büschenfelde KH
    Ann Med; 1994 Oct; 26(5):365-9. PubMed ID: 7530015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breaking the rules: the unconventional recognition of HLA-B27 by CD4+ T lymphocytes as an insight into the pathogenesis of the spondyloarthropathies.
    Boyle LH; Hill Gaston JS
    Rheumatology (Oxford); 2003 Mar; 42(3):404-12. PubMed ID: 12626789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal models of HLA-B27-associated diseases: new outcomes.
    Hacquard-Bouder C; Ittah M; Breban M
    Joint Bone Spine; 2006 Mar; 73(2):132-8. PubMed ID: 16377230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin.
    Bertrand V; Quéré S; Guimbaud R; Sogni P; Chauvelot-Moachon L; Tulliez M; Lamarque D; Charreire J; Giroud JP; Couturier D; Chaussade S; Breban M
    Eur Cytokine Netw; 1998 Jun; 9(2):161-70. PubMed ID: 9681392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The recognition of abnormal forms of HLA-B27 by CD4+ T cells.
    Boyle LH; Goodall JC; Gaston JS
    Curr Mol Med; 2004 Feb; 4(1):51-8. PubMed ID: 15011959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Course of gut inflammation in spondylarthropathies and therapeutic consequences.
    Mielants H; Veys EM; Cuvelier C; De Vos M
    Baillieres Clin Rheumatol; 1996 Feb; 10(1):147-64. PubMed ID: 8674145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.